ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

JNJ Johnson and Johnson

151.44
0.22 (0.15%)
15 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Johnson and Johnson NYSE:JNJ NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.22 0.15% 151.44 152.21 150.70 151.85 8,254,173 00:29:57

Reckitt Benckiser Gets U.K. Regulatory Approval to Buy K-Y Lubricants

12/08/2015 9:46am

Dow Jones News


Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Johnson and Johnson Charts.

By Saabira Chaudhuri

Reckitt Benckiser Group PLC has received regulatory clearance from U.K. authorities to buy the K-Y brand of intimate lubricants from Johnson & Johnson, but will be forced to license out the brand for several years.

The U.K. consumer-goods company, which already owns condom brand Durex, agreed to buy K-Y last year. The acquisition ran into a roadblock in December when the U.K.'s Competition and Markets Authority said the deal could result in a "substantial lessening of competition" and higher prices for consumers because no other brands are available in many shops.

At the time, the regulator asked Reckitt and J&J to take steps to allay their concerns. Then in January, the CMA said measures put forward by Reckitt since December were found to be insufficient and announced it was launching an investigation into the deal.

Wednesday, Reckitt said the U.K. regulator is requiring it to license the K-Y brand in the U.K. to a third party for eight years. During that period, the company selling K-Y would create its own brand, following which Reckitt would take back control of K-Y.

The clearance comes after Reckitt in April failed to get approval from New Zealand's Commerce Commission to buy K-Y's regional business there, saying it would damage competition.

Chief Executive Rakesh Kapoor told journalists last month that the U.K. and New Zealand businesses were "a very tiny part" of the K-Y portfolio, and that the U.S. was the most significant. K-Y is sold in over 50 countries, but its biggest revenue streams are the U.S., Canada and Brazil.

Under Mr. Kapoor, Reckitt has been shifting its focus toward higher-margin consumer health products, and in July the Slough, England-based company's health unit reported a 13% rise in comparable sales for the first half. At the time, Mr. Kapoor said the K-Y acquisition had helped results.

Write to Saabira Chaudhuri at saabira.chaudhuri@wsj.com

-0- 
 

1 Year Johnson and Johnson Chart

1 Year Johnson and Johnson Chart

1 Month Johnson and Johnson Chart

1 Month Johnson and Johnson Chart

Your Recent History

Delayed Upgrade Clock